---
schema_version: "secwatch.filing_event.v1"
accession: "0001206774-25-000377"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T15:57:03.598395+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Clorox amends bylaws to add cure process for shareholder nomination deficiencies

## Summary
- Board adopted amended bylaws effective May 19, 2025.
- New cure process allows shareholders to fix deficiencies in director nomination notices.
- Company will notify shareholders of deficiencies and provide a specified cure period.
- Amendment applies to nomination notices received within the bylaws' time window.

## SEC filing metadata
- accession: 0001206774-25-000377
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000120677425000377/0001206774-25-000377-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000120677425000377/clx4489401-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001206774-25-000377
- JSON: https://secwatch.observer/filing/0001206774-25-000377.json
- Plain text: https://secwatch.observer/filing/0001206774-25-000377.txt

## Key facts
- Governance Changes
  CLOROX CO /DE/: Amended and restated bylaws to implement a cure process for deficiencies in director nomination notices submitted by shareholders. The Company will notify shareholders of deficiencies, allowing them an opportunity to cure within a specified time period (effective 2025-05-19).
  - Change: bylaw amendment
  - Effective: 2025-05-19
  source text: The Board of Directors of The Clorox Company (the “Company”) amended and restated the Company’s bylaws (the “Bylaws”), effective May 19, 2025. The amendments implement a cure process for certain deficiencies in director nomination notices submitted by shareholders. For nomination notices received by the Company within the time period specified in the Bylaws, the Company will notify shareholders of deficiencies in the notice and there will be an opportunity to cure such deficiencies within the time period specified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/21076/000120677425000377/0001206774-25-000377-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.